Successive delivery of medicines for drug programs in 3 packages
Original notice title
Sukcesywna dostawa leków do programów lekowych – 3 pakiety
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
55 / 100
Risk factors
No estimated value is disclosed, making it difficult to gauge contract size and potential profitability.
The submission deadline is approximately 29 days from publication, which may be tight for document collection and appro...
Submission deadline in 5 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Supplies contract
- 3 lots
- Duration 12 MONTH
- Successive delivery of medicinal products for drug programs (3 packages).
- Product categories include immunoglobulins, natalizumab formulations, and other pharmaceuticals under CPV 33600000.
Show full summary
This tender by Instytut Psychiatrii i Neurologii (Warsaw, Poland) is for the successive delivery of medicinal products for drug programs divided into 3 packages (lots). The procedure is open, with award based solely on price (100%). Key requirements include electronic submission, Polish language, and a 12-month contract duration. No estimated value is published. Detailed eligibility criteria require exclusion grounds verification and pharmaceutical wholesale/production permits. The tender is a correction of an earlier notice (369459-2026).
Risks
No estimated value is disclosed, making it difficult to gauge contract size and potential profitability.
The submission deadline is approximately 29 days from publication, which may be tight for document collection and appro...
Submission deadline in 5 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tender deadline: 2026-06-29, 08:00 UTC (10:00 CEST).
Administrative
- Electronic submission mandatory via Open portal
- Submission language: Polish.
Award Criteria
Lot 1
Lot 2
Lot 3
Buyer
Name
Instytut Psychiatrii i Neurologii
Location
Warszawa, POL
Buyer profile
Identifier
5250009387
Lots (3)
LOT-0001
Pakiet nr 1
Successive delivery of immunoglobulin human solution for subcutaneous administration 200 mg/ml.
Location
Duration
Category
Selection criteria
Deadline
Award details
Show original TED data
Original TED description
Immunoglobulin Humannum roztwór do podawania podskórnego 200 mg/ml
LOT-0002
Pakiet nr 2
Successive delivery of natalizumab concentrate for solution for infusion, 300 mg, 1 vial of 15 ml.
Location
Duration
Category
Selection criteria
Deadline
Award details
Show original TED data
Original TED description
Natalizumab, koncentrat do sporządzania roztworu do infuzji, 300 mg, 1 fiol. po 15 ml
LOT-0003
Pakiet nr 3
Successive delivery of natalizumab 150 mg/ml, 2 ampoules of 1 ml.
Location
Duration
Category
Selection criteria
Deadline
Award details
Show original TED data
Original TED description
Natalizumab 150 mg/ml 2 amp-strz. po 1 ml
Procurement Details
- Publication date
- 31 May 2026
- Notice type
- Contract notice — standard
- Languages
- Polish
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 372668-2026
- Source notice ID
- 21077da3-355b-43f4-bfc8-3d96f1db6f1f
Documents (1)
Similar tenders
Poland – Various medicinal products – ZP.220.99.26 Dostawa różnych produktów leczniczych, żywności medycznej oraz preparatów do żywienia pacjentów na potrzeby
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Slovakia – Medicinal products for the alimentary tract and metabolism – Liečivá pre výživovú sústavu a látkovú premenu
Belgium – Immunoglobulins – Immunoglobulinen voor intraveneuze toediening (IVIG)
Belgium – Plasma extracts – Raamovereenkomst voor de aankoop van IV Immunoglobulinen en Protrombine complex concentraat
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
55 / 100
Risk factors
No estimated value is disclosed, making it difficult to gauge contract size and potential profitability.
The submission deadline is approximately 29 days from publication, which may be tight for document collection and appro...
Submission deadline in 5 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications